» Articles » PMID: 11900586

Laboratory Diagnosis of Dysfibrinogenemia

Overview
Specialty Pathology
Date 2002 Mar 20
PMID 11900586
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Dysfibrinogenemia is a coagulation disorder caused by a variety of structural abnormalities in the fibrinogen molecule that result in abnormal fibrinogen function. It can be inherited or acquired. The inherited form is associated with increased risk of bleeding, thrombosis, or both in the same patient or family. Traditionally, dysfibrinogenemia is diagnosed by abnormal tests of fibrin clot formation; the thrombin time and reptilase time are the screening tests, and the fibrinogen clotting activity-antigen ratio is the confirmatory test. The inherited form is diagnosed by demonstrating similar laboratory test abnormalities in family members, and if necessary by analysis of the fibrinogen protein or fibrinogen genes in the patient. The acquired form is diagnosed by demonstrating abnormal liver function tests and by ruling out dysfibrinogenemia in family members. This article reviews the laboratory testing of dysfibrinogenemia and presents an algorithm for sequential test selection that can be used for diagnosis.

Citing Articles

Association between coagulation indicators and menorrhagia among women in Kenya.

Marabi P, Musyoki S, Monari F, Kosiyo P, Ouma C Afr J Lab Med. 2024; 13(1):2438.

PMID: 39364033 PMC: 11447587. DOI: 10.4102/ajlm.v13i1.2438.


Clinical phenotype and laboratory characteristics of 93 patients with congenital fibrinogen disorders from unrelated 36 families.

Tian D, Liang J, Gao H, Xu X, Nie W, Yin M Res Pract Thromb Haemost. 2024; 8(4):102445.

PMID: 38953055 PMC: 11215109. DOI: 10.1016/j.rpth.2024.102445.


Investigation of acquired dysfibrinogenaemia in adult patients with sepsis using fibrinogen function vs. concentration ratios: a cross-sectional study.

Toenges R, Steiner M, Weber C, Miesbach W Front Med (Lausanne). 2023; 10:1294301.

PMID: 38152302 PMC: 10752225. DOI: 10.3389/fmed.2023.1294301.


Effect of chamomile intake on blood coagulation tests in healthy volunteers: a randomized, placebo-controlled, crossover trial.

Schwartz J, Romeiser J, Kimura R, Senzel L, Galanakis D, Halper D Perioper Med (Lond). 2023; 12(1):51.

PMID: 37730613 PMC: 10510223. DOI: 10.1186/s13741-023-00339-7.


Congenital dysfibrinogenemia misdiagnosed and inappropriately treated as acute fatty liver in pregnancy: A case report and review of literature.

Jia Y, Zhang X, Wu Y, Wang Q, Yang S World J Clin Cases. 2022; 10(35):12996-13005.

PMID: 36569010 PMC: 9782930. DOI: 10.12998/wjcc.v10.i35.12996.